1.
J Clin Med
; 13(17)2024 Aug 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-39274244
RESUMO
Despite advances in ablative therapies, outcomes remain less favorable for persistent atrial fibrillation often due to presence of non-pulmonary vein triggers and abnormal atrial substrates. This review highlights advances in ablation technologies and notable scientific literature on clinical outcomes associated with pursuing adjunctive ablation targets and substrate modification during persistent atrial fibrillation ablation, while also highlighting notable future directions.